Published in Gastroenterology on June 01, 1983
Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen. J Clin Microbiol (1991) 0.84
Hepatitis B surface antigen and polymerized albumin binding activity in sheep serum. Proc Natl Acad Sci U S A (1984) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
Microstructural maturation of the human brain from childhood to adulthood. Neuroimage (2008) 5.30
Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med (2000) 5.27
Antibody to hepatitis-B-virus core in man. Lancet (1973) 4.24
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19
Management of hepatitis B: 2000--summary of a workshop. Gastroenterology (2001) 4.17
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med (1989) 3.45
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med (1990) 2.99
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis (1997) 2.98
NIH conference. Hepatocellular carcinoma. Ann Intern Med (1988) 2.94
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med (1986) 2.85
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 2.49
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
Genotypic analysis of hepatitis C virus in American patients. Hepatology (1994) 2.33
Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med (1978) 2.30
Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature (1985) 2.29
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology (1991) 2.25
Measurements of iron status in patients with chronic hepatitis. Gastroenterology (1992) 2.22
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology (1991) 2.15
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest (1996) 2.04
The effect of age on the relative potency of midazolam and diazepam for sedation in upper gastrointestinal endoscopy. J Clin Gastroenterol (1990) 2.02
Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02
Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology (1992) 1.99
Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Ann Surg (1999) 1.98
Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med (1974) 1.98
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med (1981) 1.96
Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology (1987) 1.94
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med (1991) 1.92
Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med (1974) 1.92
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology (1988) 1.91
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
Dietary restriction and aging: the initiation of a primate study. J Gerontol (1990) 1.84
Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology (1991) 1.82
Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet (1978) 1.82
SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother (1978) 1.81
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther (2012) 1.81
Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology (1996) 1.78
Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest (1991) 1.77
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis (1995) 1.74
Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol (2001) 1.67
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med (1987) 1.61
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
Toward universal vaccination against hepatitis B virus. N Engl J Med (1989) 1.60
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology (1999) 1.58
Defining the relationship between obesity and total joint arthroplasty. Obes Res (2001) 1.58
Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology (1991) 1.57
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2008) 1.54
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
In-vitro comparison of erythromycin, lincomycin, and clindamycin. Br Med J (1970) 1.54
Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest (1983) 1.52
Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis (1998) 1.51
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol (2001) 1.50
Hepatic organic anion uptake in the rat. J Clin Invest (1975) 1.49
Drug-induced liver injury: mechanisms and test systems. Hepatology (2001) 1.49
Hepatitis C in asymptomatic blood donors. Hepatology (1997) 1.48
Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology (1987) 1.45
The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology (1991) 1.45
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology (1998) 1.44
Lamivudine for chronic delta hepatitis. Hepatology (1999) 1.44
Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol (1990) 1.43
Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer (1989) 1.43
Therapy of hepatitis C. Semin Liver Dis (1995) 1.42
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene (2006) 1.41
Methotrexate therapy of primary biliary cirrhosis: promising but worrisome. Gastroenterology (1991) 1.41
Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology (1991) 1.41
Hypersensitivity to Colchicine. Ann Rheum Dis (1947) 1.41
Viral hepatitis, type B, in experimental animals. Am J Med Sci (1976) 1.41
Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis. Am J Gastroenterol (1990) 1.41